These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8373834)

  • 1. Bone scintigraphy in breast cancer: a ten-year follow-up study.
    Crippa F; Seregni E; Agresti R; Bombardieri E; Buraggi GL
    J Nucl Biol Med (1991); 1993 Jun; 37(2):57-61. PubMed ID: 8373834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer.
    Pauwels EK; Heslinga JM; Zwaveling A
    Clin Oncol; 1982 Mar; 8(1):25-32. PubMed ID: 6280915
    [No Abstract]   [Full Text] [Related]  

  • 3. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of skeletal scintigraphy for oncological practice].
    Kampmann H; Buchelt L
    Rontgenblatter; 1983 Oct; 36(10):342-51. PubMed ID: 6227979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer.
    Crippa F; Bombardieri E; Seregni E; Castellani MR; Gasparini M; Maffioli L; Pizzichetta M; Buraggi GL
    J Nucl Biol Med (1991); 1992; 36(1):52-5. PubMed ID: 1450226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of a computer-aided diagnosis system for whole-body bone scintigraphy to detect bone metastasis in breast cancer patients.
    Urano M; Maki Y; Nishikawa H; Kawai T; Shiraki N; Shibamoto Y
    Ann Nucl Med; 2017 Jan; 31(1):40-45. PubMed ID: 27686468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A re-evaluation of isotope screening for skeletal metastases in node-negative breast cancer.
    Gudgeon CA; Werner ID; Dent DM
    S Afr Med J; 1996 Feb; 86(2):166-9. PubMed ID: 8619145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
    Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
    Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphy with 99mTc-phosphonate and 67gallium in patients suspected of primary bone tumors.
    Edeling CJ
    Nuklearmedizin; 1982 Aug; 21(4):136-9. PubMed ID: 6959075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bone scans in the initial assessment of operable patients with breast carcinoma.
    Strender LE; Lagergren C; Wallgren A; Liljevall S
    Acta Radiol Oncol; 1981; 20(3):187-91. PubMed ID: 6270978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of skeletal scintigraphy in the therapy of breast cancer].
    Köhler AH; Weidig W
    Zentralbl Chir; 1982; 107(22):1433-9. PubMed ID: 7164627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone scintigraphy in breast cancer: a ten-year follow up study].
    Rajtár M; Esik O; Almási L; Csernay L
    Orv Hetil; 1990 Sep; 131(35):1907-8, 1911-2. PubMed ID: 2216412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with 7,604 bone scintigraphies at time of operation for breast cancer 1977-1987.
    Thomsen HS; Lund JO; Munck O; Andersen KW
    Dan Med Bull; 1989 Oct; 36(5):481-3. PubMed ID: 2553340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scintigraphy using Technetium 99 m pyrophosphate in detection of bone metastasis of breast cancers. Analysis of 310 examinations].
    Ducassou D; Leccia F; Bonichon F; Meynard G
    Nouv Presse Med; 1977 May; 6(20):1729-32. PubMed ID: 194221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scintigraphic diagnosis of occult bone metastases in patients with operable breast cancer.
    Stanchev V; Grigorov L; Ouzounov I; Mitov F
    Folia Med (Plovdiv); 1986; 28(2):29-33. PubMed ID: 3108109
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of bone scintigraphy in the follow-up of osteogenic sarcoma.
    Körholz D; Wirtz I; Vosberg H; Rüther W; Jürgens H; Göbel U
    Eur J Cancer; 1996 Mar; 32A(3):461-4. PubMed ID: 8814693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The problem of false positives in bone scintigraphy in patients with breast neoplasms. A follow-up at 10 years].
    Campostrini F; Di Marco A; Micciolo R; Grandinetti A; Griso C; Palazzi M; Zamboni M
    Radiol Med; 1990 May; 79(5):539-43. PubMed ID: 2113699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The place of bone scintigraphy in the diagnosis and follow-up of Ewing's sarcoma].
    Schaub T; Düber C; Antoniadis A; Eissner D; Greinacher I; Gutjahr P; Thelen M
    Rofo; 1989 Apr; 150(4):395-401. PubMed ID: 2539615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study.
    Yilmaz MH; Ozguroglu M; Mert D; Turna H; Demir G; Adaletli I; Ulus S; Halac M; Kanberoğlu K
    Med Oncol; 2008; 25(3):257-63. PubMed ID: 18040900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.